← 홈

CGT

1,235개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicstalePoseida Therapeutics, Inc.Phase 2

autologous anti-BCMA chimeric antigen receptor T cells (autologous anti-BCMA chimeric antigen receptor T cells)

ITP · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 96.6%임상시험 31상태 ACTIVE
CGTBiologicstaleByron LamPhase 1

Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 1.03%임상시험 31상태 ACTIVE
CGTBiologicstaleByron LamPhase 1

injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low, injection of scAAV2-P1ND4v2 1.18x10e9 vg, injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),)

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 2.53%임상시험 31상태 ACTIVE
CGTBiologicstaleByron LamPhase 1

High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 1.03%임상시험 31상태 ACTIVE
CGTBiologicstaleByron LamPhase 1

Med (injection of scAAV2-P1ND4v2 5.81 X10e9 vg, injection of scAAV2-P1ND4v2 5.81 X10e9 vg (Med))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 73.59%임상시험 31상태 ACTIVE
CGTBiologicstaleGuangzhou FineImmune Biotechnol…Phase 1

tumor-specific TCR-T cells (tumor-specific TCR-T cells)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 20%임상시험 31상태 RECRUITING
CGTBiologicChinese PLA General HospitalPhase 2

Anti-BCMA-CD19 CAR-T cells (Anti-BCMA-CD19 CAR-T cells)

IgG4 Related Disease; B-cell Mediated Autoimmune Disorders · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 30상태 RECRUITING
CGTBiologicInstituto de Investigación Hosp…Phase 1

Autologous CD19/CD22 CAR T cells (Autologous CD19/CD22 CAR T cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 30상태 RECRUITING
CGTBiologicstaleVaxcell Bio, Co., Ltd.Phase 1

Autologous Natural Killer Cell Therapy (Autologous Natural Killer Cell Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 30상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 1

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 30상태 RECRUITING
CGTBiologicstaleMinsk Scientific-Practical Cent…Phase 2

CD19+22 CAR-T cells (CD19+22 CAR-T cells)

Acute Lymphobkastic Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 1%임상시험 30상태 RECRUITING
CGTBiologicstaleCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 30상태 ACTIVE
CGTBiologicAlex's Lemonade Stand FoundationPhase 1

GD2 CAR T cells (GD2 CAR T cells)

Neuroblastoma · GD2

#GD2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 30상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Preclinical

T cell injection targeting CD19 chimeric antigen receptor (T cell injection targeting CD19 chimeric antigen receptor)

Systemic Lupus Erythematosus; Idiopathic Inflammatory Myopathies · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 30상태 ACTIVE
CGTBiologicstaleKara Yakhteh Tajhiz Azma CompanyPhase 2

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

Relapse/Refractory B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 94%임상시험 30상태 RECRUITING
CGTBiologicstaleTakedaPhase 1

anti-CD19 CAR-NK (anti-CD19 CAR-NK)

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 30상태 RECRUITING
CGTBiologicstaleHrain Biotechnology Co., Ltd.Preclinical

anti-CD19-CAR vector-transduced T cells (anti-CD19-CAR vector-transduced T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+5
효능 ORR 32%임상시험 30상태 ACTIVE
CGTBiologicstaleBeijing Bio-Targeting Therapeut…Phase 2

oncolytic virus (oncolytic virus)

Glioblastoma (GBM) · Glioblastoma (GBM)

#GlioblastomaGBM#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 28%임상시험 30상태 RECRUITING
CGTBiologicstaleGlycostem Therapeutics BVPhase 1

umbilical cord blood NK cells (umbilical cord blood NK cells)

Neuroblastoma · Soft Tissue Sarcoma (STS)

#SoftTissueSarcomaSTS#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 30상태 RECRUITING
CGTBiologicShanghai Cell Therapy Group Co.…Phase 1

Fast CAR T cells (Fast CAR T cells)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 28상태 RECRUITING

8 / 62 페이지

← 이전다음 →